Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

tolvaptan Oral Tablet [Samsca]

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Tolvaptan [Jynarque® (USA); Jinarc® (EU, Canada); Samsca® (Japan)] is a highly selective vasopressin V2 receptor antagonist… Expand
  • table 1
  • table 2
Is this relevant?
2016
2016
Tolvaptan (Samsca®) is an orally administered highly selective vasopressin V2 receptor antagonist that increases the clearance of… Expand
Is this relevant?
2011
2011
2. CHMP Assessment Report for Samsca® (EMEA). [Citado 12/1/2010]. Disponible en: http://www.ema.europa.eu/ humandocs/PDFs/EPAR… Expand
Is this relevant?
2010
2010
2. CHMP Assessment Report for Samsca® (EMEA). [Citado 12/1/2010]. Disponible en: http://www.ema.europa.eu/ humandocs/PDFs/EPAR… Expand
Is this relevant?